Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intrahepatic Bile Duct Carcinoma”

271 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 271 results

Not applicableLooking for participantsNCT06910722
What this trial is testing

Liver Transplantation for Locally Advanced Intrahepatic Cholangiocarcinoma After SIRT and Chemotherapy

Who this might be right for
Intrahepatic CholangiocarcinomaLocally Advanced Intrahepatic Cholangiocarcinoma
Assistance Publique - Hôpitaux de Paris 36
Testing effectiveness (Phase 2)Looking for participantsNCT06925516
What this trial is testing

A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 38
Not applicableWithdrawnNCT05240040
What this trial is testing

Treat Primary and Metastatic Liver Tumors

Who this might be right for
Intrahepatic CholangiocarcinomaLiver TumorMetastatic Cancer+1 more
Methodist Health System
Not applicableLooking for participantsNCT06735560
What this trial is testing

Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, ICC or NEN

Who this might be right for
Hepatocellular Carcinoma (HCC)Intrahepatic Cholangiocarcinoma (Icc)Neuroendocrine Tumors
Nantes University Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT06664021
What this trial is testing

Exploring the Efficacy and Safety of Tislelizumab in Combination With S-1 in the Treatment of Patients With Postoperative Recurrent High-risk Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Anhui Provincial Hospital 60
Testing effectiveness (Phase 2)Study completedNCT04301778
What this trial is testing

Durvalumab and SNDX-6532 Following Chemo or Radio-Embolization for Patients With Intrahepatic Cholangiocarcinoma

Who this might be right for
Unresectable Intrahepatic Cholangiocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 5
Testing effectiveness (Phase 2)Study completedNCT04526106
What this trial is testing

REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors

Who this might be right for
FGFR2 AmplificationFGFR2 Gene MutationFGFR2 Gene Fusion/Rearrangement+5 more
Elevar Therapeutics 490
Early research (Phase 1)Study completedNCT01668134
What this trial is testing

Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma

Who this might be right for
Carcinoma, HepatocellularIntrahepatic Cholangiocarcinoma
Washington University School of Medicine 28
Testing effectiveness (Phase 2)Study completedNCT00005938
What this trial is testing

DX-8951f in Treating Patients With Biliary Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Daiichi Sankyo
Testing effectiveness (Phase 2)Ended earlyNCT04989218
What this trial is testing

Durvalumab and Tremelimumab With Platinum-based Chemotherapy in Intrahepatic Cholangiocarcinoma (ICC)

Who this might be right for
Cholangiocarcinoma
University of Alabama at Birmingham 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT04251715
What this trial is testing

MFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma

Who this might be right for
Liver and Intrahepatic Bile Duct CarcinomaStage III Intrahepatic Cholangiocarcinoma AJCC v8Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8+3 more
OHSU Knight Cancer Institute 5
Not applicableUnknownNCT05681949
What this trial is testing

Therapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor Boards

Who this might be right for
Hepatocellular CarcinomaFibrolamellar Hepatocellular CarcinomaCholangiocarcinoma, Perihilar+3 more
Charite University, Berlin, Germany 1,200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06648525
What this trial is testing

Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Harbin Medical University 68
Not applicableStudy completedNCT03320980
What this trial is testing

RALPPS in Patients With Hilar and Intrahepatic Cholangiocarcinoma

Who this might be right for
Hilar CholangiocarcinomaIntrahepatic Cholangiocarcinoma
Moscow Clinical Scientific Center 30
Early research (Phase 1)Study completedNCT01825603
What this trial is testing

ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer

Who this might be right for
Ampulla of Vater AdenocarcinomaGallbladder AdenocarcinomaMetastatic Pancreatic Adenocarcinoma+17 more
University of Nebraska 17
Large-scale testing (Phase 3)UnknownNCT02548195
What this trial is testing

Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Shanghai Zhongshan Hospital 286
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06375642
What this trial is testing

A Single Arm, Single Centered Phase II Trial on the Combination of Adebrelimab, Surufatinib and Irinotecan Liposome-based HAIC in Advanced iCC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Study completedNCT04361331
What this trial is testing

Two-cohort Study of Toripalimab(PD1)+Lenvatnib, or Gemox+Lenvatinib in Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma, Intrahepatic
Shanghai Zhongshan Hospital 61
Testing effectiveness (Phase 2)Study completedNCT02496741
What this trial is testing

Metformin And Chloroquine in IDH1/2-mutated Solid Tumors

Who this might be right for
GliomaCholangiocarcinomaChondrosarcoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 15
Not applicableStudy completedNCT04072250
What this trial is testing

Surgery for Recurrent Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma, IntrahepaticRecurrence CholangiocarcinomaRe-hepatectomy
Chang Gung Memorial Hospital 216
Load More Results